文献速递临床试验与 GCP流行病学与生物统计

立即袋鼠式母亲护理对印度恰蒂斯加尔邦地区医院低出生体重新生儿死亡率和培养阳性脓毒症的影响(PRISM研究):阶梯楔形整群随机试验方案

Effect of immediate kangaroo mother care (iKMC) on neonatal mortality and culture-positive sepsis in low-birth-weight neonates in district hospitals in Chhattisgarh, India (PRISM study): protocol for a stepped-wedge cluster randomized trial.
PubMed 文献 · Trials · 2025-10-09

该方案拟在印度恰蒂斯加尔邦10家地区医院开展42个月的阶梯楔形整群随机试验,纳入出生体重1000-1799克且生后12小时内可启动袋鼠式母亲护理的新生儿。干预为生后12小时内启动持续皮肤接触并持续至出院或体重达2.5公斤,主要结局为28日龄前全因新生儿死亡和/或培养阳性脓毒症的发生率,采用广义线性混合模型报告相对危险度及95%置信区间,按意向性分析。

要点

  • PRISM试验在印度10家地区医院评估立即袋鼠式母亲护理对低出生体重新生儿死亡和培养阳性脓毒症的影响。
  • 纳入标准为出生体重1000-1799克且生后12小时内可启动袋鼠式母亲护理的新生儿。
  • 主要结局为28日龄前全因新生儿死亡和/或培养阳性脓毒症的发生率,采用意向性分析。

核心结论

  • 若证实可降低脓毒症或新生儿死亡风险,该试验将为立即袋鼠式母亲护理在地区医院的安全性和有效性提供证据,并推动其在印度及其他中低收入国家的实施和推广。

研究设计与样本

  • 阶梯楔形整群随机试验,在印度恰蒂斯加尔邦10家地区医院开展,为期42个月。
  • 基线期6个月后,立即袋鼠式母亲护理在10个研究点按3个月间隔分10个步骤依次实施。
  • 纳入出生体重1000-1799克且生后12小时内可启动袋鼠式母亲护理并入住参与医院的新生儿。
  • 对照期为常规袋鼠式母亲护理,按各站点现行做法执行。
  • 主要结局为28日龄前全因新生儿死亡和/或培养阳性脓毒症的发生率,采用广义线性混合模型报告相对危险度及95%置信区间,按意向性分析。

关键数值与推荐

  • 干预包括生后12小时内启动与母亲或亲属的持续皮肤接触,持续袋鼠式母亲护理至出院或体重达2.5公斤,并提供母乳喂养支持。
  • 主要结局为28日龄前全因新生儿死亡和/或培养阳性脓毒症的发生率,报告相对危险度及95%置信区间。
  • 试验注册号为印度临床试验注册中心CTRI/2024/09/074269,注册日期2024年9月24日。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The high rates of culture-positive sepsis, sepsis-related mortality, and multidrug resistance in neonates admitted to special care newborn units in district hospitals (DH) in India necessitate urgent actions to prevent infections in these settings. Immediate kangaroo mother care (iKMC), initiated before stabilization within the first few hours of life, has been shown to reduce neonatal mortality among low birth weight (LBW) neonates admitted to tertiary care hospitals. However, the effect of iKMC on sepsis and sepsis-related mortality, particularly in DH, remains unclear. This study aims to evaluate whether iKMC can lower the incidence of mortality or culture-positive sepsis in LBW neonates admitted to neonatal units in district hospitals. METHODS: This stepped-wedge cluster randomized trial will be conducted in ten district hospitals in Chhattisgarh, India, over 42 months. All neonates weighing between 1000 and 1799 g at birth and admitted to the participating hospitals, in whom KMC can be initiated within 12 h of life, will be eligible for inclusion. During the pre-intervention period (control), routine KMC will be practiced at the sites as is. Following a baseline period of 6 months, iKMC will be implemented sequentially in ten steps across the ten study sites at intervals of 3 months. The intervention includes initiating continuous skin-to-skin contact with the mother or relatives within 12 h of life, continuing KMC until discharge or weight 2.5 kg, and providing breastfeeding support. The primary outcome is the incidence of all-cause neonatal mortality and/or culture-positive sepsis until 28 days of life. Relative risks with 95% confidence intervals will be reported and analyzed using a generalized linear mixed model. An intention-to-treat analysis will be conducted. DISCUSSION: The PRISM (Protective Role of Immediate KMC in neonatal Sepsis and Mortality) trial will sequentially implement iKMC for LBW neonates in ten district hospitals with a relatively high burden of sepsis in India. If proven effective in reducing the risks of sepsis or neonatal mortality, the trial will provide necessary evidence for its safety and efficacy, as well as the impetus for implementing and upscaling the intervention in district hospitals across India and other low- and middle-income countries. TRIAL REGISTRATION: Clinical Trial Registry of India, CTRI/2024/09/074269. Registered on 24/09/2024, https://ctri.nic.in/Clinicaltrials/pmaindet2.php?EncHid=MTE0MzY3&Enc=&userName=immediate%20kangaroo%20mother%20care .

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Prakash S, Jindal A, Jain K, et al. Effect of immediate kangaroo mother care (iKMC) on neonatal mortality and culture-positive sepsis in low-birth-weight neonates in district hospitals in Chhattisgarh, India (PRISM study): protocol for a stepped-wedge cluster randomized trial. Trials. 2025. PMID: 41068937. doi:10.1186/s13063-025-09083-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。